MicroPort Scientific has been granted a patent for an active implantable medical device that analyzes cardiac cycles using endocardial electrogram signals. The device compares parametric curves to reference curves to quantify fusion rates, aiding in the management of cardiac conditions. GlobalData’s report on MicroPort Scientific gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on MicroPort Scientific, Glucose monitoring wearbles was a key innovation area identified from patents. MicroPort Scientific's grant share as of January 2024 was 46%. Grant share is based on the ratio of number of grants to total number of patents.
Implantable device for analyzing cardiac cycle fusion rate
A recently granted patent (Publication Number: US11865353B2) discloses an active implantable medical device designed to quantify fusion rates in cardiac cycles. The device includes memory with instructions for capturing endocardial electrogram signals, deriving temporal components, generating parametric curves, and comparing them with reference curves to calculate descriptive parameters. In the event of a fusion situation, a metric is generated to quantify the fusion rate based on the calculated values. The device also involves applying stimulation with specific atrioventricular delays and pacing rates to obtain reference curves for complete capture and ventricular spontaneous rhythm situations.
Furthermore, the patent includes a method for quantifying fusion rates using similar processes as the device, along with a non-transitory computer-readable medium with instructions for executing the fusion rate quantification process. The method involves capturing EGM signals, deriving temporal components, generating parametric curves, comparing them with reference curves, and calculating descriptive parameters to quantify fusion rates. Additionally, the method includes applying specific stimulations to obtain reference curves for different cardiac cycle situations. Overall, the patent aims to provide a comprehensive system for accurately quantifying fusion rates in cardiac cycles using advanced technological processes and algorithms.
To know more about GlobalData’s detailed insights on MicroPort Scientific, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
